ReviewCancer management and research2021
Impact of COVID-19 Pandemic on Ovarian Cancer Management: Adjusting to the New Normal.
Review in Cancer management and research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 39 citations in OpenAlex.
- Changes in Ultrasound-Based Risk Stratification and Surgical Selection of Adnexal Masses During the COVID-19 Pandemic: A Single-Center Retrospective Study.Diagnostics (Basel, Switzerland) · 2026Article
- Article
- COVID-19 pandemic and healthcare utilization in ovarian cancer patients.Gynecologic oncology reports · 2026Article
- Impact of the COVID-19 pandemic on ovarian cancer diagnosis, treatment, and survival in a Swiss tertiary care hospital - a conclusion five years after the outbreak of the pandemic.Frontiers in oncology · 2026Article
- Patient Voices: What Can We Learn From the Covid-19 Pandemic About Follow-Up Care in Gynaecologic Oncology?Health expectations : an international journal of public participation in health care and health policy · 2025Article
- Global determinants of gynecologic cancer incidence and mortality: A cluster-based analysis with predictive insights.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2025Article
- Impact of the COVID-19 pandemic on cancer recurrence rates in patients with ovarian cancer.Gynecologic oncology reports · 2025Article
- Predictors of quality of life and resilience in patients with ovarian cancer during the COVID-19 pandemic: a cross-sectional study.Archives of gynecology and obstetrics · 2025Article
- Clinical Remission Rates in Patients With Epithelial Ovarian Cancer Before and After the Onset of the COVID 19 Pandemic in an Integrated Healthcare Delivery System.Cancer management and research · 2025Article
- Ovarian Cancer Retrospective European (O'CaRE) study: first-line outcomes by number of risk factors for progression.Future oncology (London, England) · 2024Article
- Article
- Ovarian Cancer Staging-How CT Scan Descriptions Differ from Surgical Findings.Journal of clinical medicine · 2024Article
- Patient care and access to clinical trials in gynaecological oncology: global implications of the early phase of the COVID-19 pandemic.Archives of gynecology and obstetrics · 2024Article
- Impact of the Coronavirus Disease 2019 pandemic on neoadjuvant chemotherapy use in patients diagnosed with epithelial type ovarian cancer.Frontiers in oncology · 2024Article
- Factors Associated With Online Patient-Provider Communications Among Cancer Survivors in the United States During COVID-19: Cross-sectional Study.JMIR cancer · 2023Article
- The Experience of COVID-19 in a Sample of Gynecological Cancer Patients Undergoing Chemotherapy: A Focus on the Psychological Implications.International journal of environmental research and public health · 2023Article
- Application of machine learning techniques for predicting survival in ovarian cancer.BMC medical informatics and decision making · 2022Article
- Impact of the COVID-19 Pandemic on Diagnosis and Management of Gynecological Cancer: A Single-Center Analysis.Medicina (Kaunas, Lithuania) · 2022Observational
- Cancer patients attending treatment during COVID-19: intolerance of uncertainty and psychological distress.Journal of cancer survivorship : research and practice · 2022Article
- Assessment of anxiety/depression among cancer patients before and during the COVID-19 pandemic.Psycho-oncology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
Abstract
COVID-19, also known as the coronavirus disease 2019, is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) declared pandemic by the World Health Organization (WHO). As the world faces the coronavirus disease 2019 crisis, the oncology community is being impacted by unprecedented challenges. During this trying time, patients with ovarian cancer (OC) have been affected by a delay in diagnosis, surgery, chemotherapy and radiation treatments, and oncology follow-ups being conducted via telemedicine instead of in-person visits. OC patients and their oncologists are balancing the fears of COVID-19 and cancer treatment with the consequences of delaying cancer care. The delay in treatment care that women with OC are experiencing has resulted in higher levels of cancer worry, anxiety, and depression. In this article, we succinctly review the impact of the COVID-19 pandemic on the diagnosis and treatment and ongoing clinical trials of OC. We also discuss the psychological effects of COVID-19 on women with OC and alternative therapeutic strategies to limit in-person hospital visits to reduce the spread of the disease, and the impact of COVID-19 on OC patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.